KEEL vs. CCCC
KEEL (Keel Infrastructure Corporation) and CCCC (C4 Therapeutics, Inc.) are both stocks. KEEL operates in Capital Markets (Financial Services), while CCCC operates in Biotechnology (Healthcare). Over the past 5 years, KEEL returned 5.25%/yr vs -38.34%/yr for CCCC. At a 0.30 correlation, their price movements are largely independent.
Performance
KEEL vs. CCCC - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with KEEL having a 84.68% return and CCCC slightly higher at 87.43%.
KEEL
- 1D
- 9.87%
- 1M
- -31.00%
- 6M
- 47.12%
- YTD
- 84.68%
- 1Y
- 317.31%
- 3Y*
- 35.62%
- 5Y*
- 5.25%
- 10Y*
- —
- ALL TIME*
- 14.60%
CCCC
- 1D
- -2.98%
- 1M
- -13.73%
- 6M
- 60.54%
- YTD
- 87.43%
- 1Y
- 54.31%
- 3Y*
- -1.27%
- 5Y*
- -38.34%
- 10Y*
- —
- ALL TIME*
- -29.25%
KEEL vs. CCCC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
KEEL Keel Infrastructure Corporation | 84.68% | 57.72% | -48.80% | 561.36% | -91.29% | 165.79% | 691.67% |
CCCC C4 Therapeutics, Inc. | 87.43% | -46.94% | -36.28% | -4.24% | -81.68% | -2.81% | 24.55% |
Correlation
The correlation between KEEL and CCCC is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Oct 2, 2020 | 0.30 |
Fundamentals
KEEL:
$2.62B
CCCC:
$296.52M
KEEL:
-$0.51
CCCC:
-$1.11
KEEL:
10.49
CCCC:
11.70
KEEL:
4.27
CCCC:
1.93
KEEL:
$229.28M
CCCC:
$28.71M
KEEL:
-$18.90M
CCCC:
$26.90M
KEEL:
-$149.60M
CCCC:
-$107.31M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KEEL vs. CCCC — Risk / Return Rank
KEEL
CCCC
KEEL vs. CCCC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Keel Infrastructure Corporation (KEEL) and C4 Therapeutics, Inc. (CCCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KEEL | CCCC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.32 | ||
| Sortino ratioReturn per unit of downside risk | +1.49 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.18 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 4.34 | 1.05 | +3.29 |
| Martin ratioReturn relative to average drawdown | 7.13 | 2.02 | +5.11 |
Loading charts...
Drawdowns
KEEL vs. CCCC - Drawdown Comparison
The maximum KEEL drawdown since its inception was -95.72%, roughly equal to the maximum CCCC drawdown of -97.82%. Use the drawdown chart below to compare losses from any high point for KEEL and CCCC.
Loading charts...
Drawdown Indicators
| KEEL | CCCC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.72% | -97.82% | +2.10% |
Max Drawdown (1Y)Largest decline over 1 year | -73.65% | -52.10% | -21.55% |
Max Drawdown (3Y)Largest decline over 3 years | -81.04% | -90.00% | +8.96% |
Max Drawdown (5Y)Largest decline over 5 years | -95.72% | -97.82% | +2.10% |
Current DrawdownCurrent decline from peak | -51.07% | -92.91% | +41.84% |
Average DrawdownAverage peak-to-trough decline | -67.17% | -72.27% | +5.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.75% | 26.97% | +17.78% |
Volatility
KEEL vs. CCCC - Volatility Comparison
Keel Infrastructure Corporation (KEEL) has a higher volatility of 29.29% compared to C4 Therapeutics, Inc. (CCCC) at 18.63%. This indicates that KEEL's price experiences larger fluctuations and is considered to be riskier than CCCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KEEL | CCCC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.29% | 18.63% | +10.66% |
Volatility (6M)Calculated over the trailing 6-month period | 71.73% | 63.37% | +8.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 111.13% | 97.27% | +13.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 105.29% | 117.72% | -12.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 289.41% | 112.34% | +177.07% |
Dividends
KEEL vs. CCCC - Dividend Comparison
Neither KEEL nor CCCC has paid dividends to shareholders.
Financials
KEEL vs. CCCC - Financials Comparison
This section allows you to compare key financial metrics between Keel Infrastructure Corporation and C4 Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KEEL and CCCC have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KEEL has higher volatility (29.29%) compared to CCCC (18.63%). In terms of maximum drawdown, KEEL dropped -95.72% vs CCCC's -97.82%.
KEEL currently has the higher Sharpe Ratio (2.88 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KEEL and CCCC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer